Prognostic value of biomarkers in ischemic stroke
- 00:00:15
Introduction to ischemic stroke and the importance of biomarkers for diagnosis and treatment
- 00:01:01
The relevance of the stroke problem
- 00:03:46
Determination of biomarkers
- 00:06:54
Practical application of biomarkers in stroke
- 00:13:03
Sources of biomarkers
- 00:15:37
Examples of biomarkers
- 00:21:37
Promising "omics" technologies for the search for new biomarkers
- 00:23:42
Biomarker-based therapy directions
- 00:26:00
Mexidol as an example of a neuroprotector with proven effectiveness
Lecturer: Ivan Aleksandrovich Shchukin , PhD, Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics of the Leningrad Branch of the N.I. Pirogov Russian National Research Medical University.
Announcement:
Key topics for discussion:
Key topics for discussion:
- Relevance of the problem and statistics;
- Definition of biomarkers and their importance;
- Promising biomarkers;
- The future lies in omics technologies (proteomics, metabolomics), which allow the analysis of thousands of molecules for personalized therapy;
- Clinical applications (neuroprotection and targeted therapy).
Biomarkers are the key to accurate diagnosis and personalized treatment of stroke!
- 00:00:15
Introduction to ischemic stroke and the importance of biomarkers for diagnosis and treatment
- 00:01:01
The relevance of the stroke problem
- 00:03:46
Determination of biomarkers
- 00:06:54
Practical application of biomarkers in stroke
- 00:13:03
Sources of biomarkers
- 00:15:37
Examples of biomarkers
- 00:21:37
Promising "omics" technologies for the search for new biomarkers
- 00:23:42
Biomarker-based therapy directions
- 00:26:00
Mexidol as an example of a neuroprotector with proven effectiveness